Senior Director, Gene Therapy Operations (Apheresis) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Beam Therapeutics · 5 days ago

Senior Director, Gene Therapy Operations (Apheresis)

Beam Therapeutics is a biotechnology company focused on precision genetic medicines. They are seeking a Senior Director for Gene Therapy Operations to lead a team responsible for patient coordination, treatment center onboarding, and ensuring compliance with regulatory standards for gene therapy operations.

BiotechnologyGeneticsMedicalTherapeutics
check
Comp. & Benefits
Hiring Manager
Sarah Oleson
linkedin

Responsibilities

Develop and mentor a high performing Gene Therapy Operations, Apheresis team that is focused on delivering an excellent patient and stakeholder experience for commercial gene therapy from scheduling through infusion process
Develop and execute the strategic initiative and process for Treatment Center Qualification, training and ongoing support for patient coordination, scheduling, communication, cell collection support, and drug product infusion support
Drive Workflow & Training development: Design training to qualify apheresis and treatment centers, leading treatment center activation and certification processes and providing ongoing operational oversight post-activation
Quality & Compliance oversight: Ensuring compliance with regulatory standards (FACT, AABB), managing quality records (deviations, CAPAs, change controls) and overseeing the end-to-end process for patient apheresis and product delivery. Ensure COC/COI and assist in the implementation of ISBT-128 ST-018, as needed
Partner with Quality and Patient Operations team to build a robust treatment center network including center selection, qualification, training and ongoing support. Lead field team providing onsite support
Provide Apheresis expertise to support various internal activities and external facing training development
Create and conduct Apheresis and Cell therapy lab on-boarding, assessments, training, and collection support and other areas as needed
Build metrics program that will drive data collection and analysis in support of optimizing collection procedures, efficiency, and quality
Actively engage in the identification, sharing, and adaptation of best practices cross-functionally and between centers and identify and champion industry working group initiatives that will improve overall cell and gene therapy industry and treatment experience of our patients
Work closely across functions to ensure Chain of Identify and Chain of Custody are maintained throughout the patient journey

Qualification

Gene Therapy OperationsApheresis expertiseBiotech industry experienceQIA certificationSickle Cell Disease experienceGCPsGMPs knowledgeLeadership skillsCommunication skillsProblem-solving abilitiesTeam player

Required

Bachelor's degree or the combination of education and business experience required
Minimum 10+ years (18+ years) of healthcare or related experience, including significant experience within the biotech industry (especially with cell and gene therapy products)
Strong direct apheresis experience within the last 5 years
Ability to work independently with very limited supervision
Ability to navigate and be successful in a fast-paced, highly matrixed work environment
Detail-oriented, able to assess and assimilate data and communicate objectively
Good knowledge of GCPs, GMPs, AABB, FACT/JACIE, FDA, EMEA, MHRA, regulations
Effective teaching, training, planning, and problem-solving abilities
Willingness to travel domestically (30-50% of time)
Strong team player that has patient focused approach and is solution oriented
Excellent listening, communication and interpersonal skills foster team spirit
Excellent people management skills and a strong track record of developing people/talent and organizational capability
A passion for addressing the critical unmet medical needs of patients

Preferred

Advanced degree preferred (e.g., MBA, RN, MPH, etc.)
Strong preference for experience within Sickle Cell Disease and autologous cell & gene therapy
Qualification in Apheresis (QIA) certification preferred
Experience in commercial gene or cell therapy is greatly preferred

Company

Beam Therapeutics

twittertwittertwitter
company-logo
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.

Funding

Current Stage
Public Company
Total Funding
$1.19B
2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M

Leadership Team

leader-logo
John Evans
CEO
linkedin
leader-logo
Christine Bellon
Chief Legal Officer
linkedin
Company data provided by crunchbase